Patient group calls for better understanding of drug trials in the USBMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7466.592-d (Published 09 September 2004) Cite this as: BMJ 2004;329:592
- Bob Roehr
It is important that the public be engaged at every level of decision making for all clinical research, according to Fran Visco, president of America's National Breast Cancer Coalition.
Ms Visco was speaking at a day long clinical roundtable discussion, organised by the Institute of Medicine on 2 September, to look at how to build public trust in clinical research.
“The public needs to understand how the [research] process works and on what basis decisions are made,” she said, adding that this should include resources for educating the public in much the same way that doctors' continuing education is supported.
Ms Visco outlined how her organisation has built ties with industry, government, and academic researchers to …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial